LncRNA MEG9 Promotes Inflammation and Liver Fibrosis Through S100A9 in Biliary Atresia
Topic overview
This research investigates the molecular mechanisms underlying biliary atresia, focusing on how long noncoding RNA MEG9 contributes to inflammation and liver fibrosis through S100A9 protein interactions. The study advances understanding of BA pathogenesis and may inform future therapeutic targets for this pediatric cholestatic liver disease.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. LncRNA MEG9 Promotes Inflammation and Liver Fibrosis Through S100A9 in Biliary Atresia. GlobalCastMD Medical Library. 2024-07-17. https://dev.library.globalcastmd.com/article/8885?via_space=staycurrentmd
Comments